HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoya Sakabe Selected Research

N- (3- (5- (4- bromo- 2- fluorophenylamino)- 3- cyclopropyl- 8- methyl- 2,4,7- trioxo- 3,4,7,8- tetrahydro- 2H- pyrido(2,3- d)pyrimidin- 1- yl)phenyl)methanesulfonamide

8/2010A novel MEK1/2 inhibitor induces G1/S cell cycle arrest in human fibrosarcoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoya Sakabe Research Topics

Disease

7Neoplasms (Cancer)
05/2013 - 09/2006
6Osteosarcoma (Osteogenic Sarcoma)
07/2010 - 09/2006
2Tendon Injuries
06/2011 - 01/2011
2Margins of Excision
01/2011 - 06/2008
2Fibrosarcoma
08/2010 - 07/2010
1Giant Cell Tumor of Tendon Sheath
05/2013
1Acquired Immunodeficiency Syndrome (AIDS)
05/2013
1Chondrosarcoma
10/2012
1Surgical Wound
10/2012
1Ewing Sarcoma (Sarcoma, Ewing)
01/2011
1Necrosis
01/2011
1Bone Resorption
07/2010
1Neoplasm Metastasis (Metastasis)
02/2009
1Synovial Sarcoma (Synovioma)
06/2008
1Femoral Neck Fractures
05/2006
1Hip Fractures (Intertrochanteric Fractures)
05/2006

Drug/Important Bio-Agent (IBA)

3Zoledronic Acid (Zometa)FDA Link
07/2010 - 02/2009
2Diphosphonates (Bisphosphonates)IBA
07/2010 - 07/2010
2Antineoplastic Agents (Antineoplastics)IBA
07/2010 - 07/2010
2sulforaphaneIBA
11/2007 - 09/2006
1Thallium-201IBA
05/2013
1GadoliniumIBA
05/2013
1HemosiderinIBA
05/2013
1TitaniumIBA
10/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2011
1AK 2123IBA
01/2011
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2011
1CytokinesIBA
01/2011
1N- (3- (5- (4- bromo- 2- fluorophenylamino)- 3- cyclopropyl- 8- methyl- 2,4,7- trioxo- 3,4,7,8- tetrahydro- 2H- pyrido(2,3- d)pyrimidin- 1- yl)phenyl)methanesulfonamideIBA
08/2010
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2010
1Docetaxel (Taxotere)FDA Link
07/2010
1Etoposide (VP 16)FDA LinkGeneric
07/2010
1Fluorouracil (Carac)FDA LinkGeneric
07/2010
1GemcitabineFDA Link
07/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2010
1Paclitaxel (Taxol)FDA LinkGeneric
07/2010
1Cisplatin (Platino)FDA LinkGeneric
07/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2009
1Proteins (Proteins, Gene)FDA Link
11/2007
1AlkaloidsIBA
10/2007
1cryptolepineIBA
10/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2006
1LigandsIBA
09/2006

Therapy/Procedure

3Drug Therapy (Chemotherapy)
08/2010 - 11/2007
2Myocutaneous Flap
10/2012 - 01/2011
2Radiotherapy
01/2011 - 06/2008
2Therapeutics
07/2010 - 09/2006
1Renal Dialysis (Hemodialysis)
05/2006